首页> 外文期刊>Acta Biochimica et Biophysica Sinica >Suppression of Type 1 Insulin-like Growth Factor Receptor Expression by Small Interfering RNA Inhibits A549 Human Lung Cancer Cell Invasion in vitro and Metastasis in Xenograft Nude Mice
【24h】

Suppression of Type 1 Insulin-like Growth Factor Receptor Expression by Small Interfering RNA Inhibits A549 Human Lung Cancer Cell Invasion in vitro and Metastasis in Xenograft Nude Mice

机译:小干扰RNA抑制1型胰岛素样生长因子受体表达在体外抑制A549人肺癌细胞的侵袭和异种移植裸鼠的转移。

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer invasion and metastasis, involving a variety of pathological processes and cytophysiological changes, contribute to the high mortality of lung cancer. The type 1 insulin-like growth factor receptor (IGF-1R), associated with cancer progression and invasion, is a potential anti-invasion and anti-metastasis target in lung cancer. To inhibit the invasive properties of lung cancer cells, we successfully down-regulated IGF-1R gene expression in A549 human lung cancer cells by small interfering RNA (siRNA) technology, and evaluated its effects on invasion-related gene expression, tumor cell in vitro invasion, and metastasis in xenograft nude mice. A549 cells transfected with a plasmid expressing hairpin siRNA for IGF-1R showed a significantly decreased IGF-1R expression at the mRNA level as well as the protein level. In biological assays, transfected A549 cells showed a significant reduction of cell-matrix adhesion, migration and invasion. Consistent with these results, we found that down-regulation of IGR-1R concomitantly accompanied by a large reduction in invasion-related gene expressions, including MMP-2, MMP-9, u-PA, and IGF-1R specific downstream p-Akt. Direct tail vein injections of plasmid expressing hairpin siRNA for IGF-1R significantly inhibited the formation of lung metastases in nude mice. Our results showed the therapeutic potential of siRNA as a method for gene therapy in inhibiting lung cancer invasion and metastasis.
机译:涉及多种病理过程和细胞生理变化的癌症侵袭和转移,导致肺癌的高死亡率。与癌症的进展和侵袭相关的1型胰岛素样生长因子受体(IGF-1R)是肺癌的潜在抗侵袭和抗转移目标。为了抑制肺癌细胞的侵袭特性,我们通过小干扰RNA(siRNA)技术成功下调了A549人肺癌细胞中IGF-1R基因的表达,并评估了其对体外侵袭相关基因表达,肿瘤细胞的影响移植瘤裸鼠体内的侵袭和转移。用表达发夹siRNA的IGF-1R质粒转染的A549细胞在mRNA水平和蛋白水平均显示IGF-1R表达显着降低。在生物学分析中,转染的A549细胞显示出细胞基质粘附,迁移和侵袭的显着减少。与这些结果一致,我们发现IGR-1R的下调伴随着与入侵相关的基因表达(包括MMP-2,MMP-9,u-PA和IGF-1R特异性下游p-Akt)的大量减少。直接尾静脉注射表达IGF-1R发夹siRNA的质粒可显着抑制裸鼠肺转移的形成。我们的结果表明,siRNA作为一种基因疗法可抑制肺癌的侵袭和转移,具有治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号